Professor David Maintz

University Hospital Cologne, Department of Radiology

A clinical, research and exam board career spanning 22+ years in both USA and Germany has led me to my current role as the Director, Department of Radiology at the University of Cologne. Our department is one of the Iargest academic radiology institutions in Germany, equipped with the latest technologies. In May 2016, the first IQon in Germany was installed in Cologne. Since then we have delivered a large number of publications on that topic. Other research topics of our department are oncologic and cardiac imaging, image guided interventions and artificial intelligence in radiology.

dont miss

Spectral CT: Dual layer technology helps to increase diagnostic confidence

This talk will report on the two year experience with the new dual layer spectral CT. Several studies have given scientific proof that image quality improvement can be achieved that helps to
detect and characterize pathologic lesions in different parts of the body, hereby increasing diagnostic confidence. At the same time, radiation and contrast media dose may be reduced.

EVEN MORE SEMINARS

  • Gareth Thomas BDS, MScD, PhD, FDSRCS, FRCPath: Speaking at the Oncology Convention

    Gareth Thomas BDS, MScD, PhD, FDSRCS, FRCPath
    University Hospital Southampton NHS Foundation Trust.

    Targeted therapies: aiming at the tumour micro-environment

  • Nizar Asadi: Speaking at the Oncology Convention

    Nizar Asadi
    Royal Brompton & Harefield NHS Foundation Trust

    Thoracic surgery in the treatment of lung cancer

  • Laura Allington: Speaking at the Oncology Convention

    Laura Allington
    University College London Hospitals NHS Foundation Trust

    Operational challenges of planning a new NHS high energy proton service.

  • Philip Beer MRCP, FRCPath, PhD: Speaking at the Oncology Convention

    Philip Beer MRCP, FRCPath, PhD
    ONCODNA S.A

    The evolution of oncology therapeutics in the genomic era.

  • Glenn Flux: Speaking at the Oncology Convention

    Glenn Flux
    Royal Marsden Hospital

    The emergence and resurgence of radiotherapeutics for cancer treatment